Table 1. Preclinical Oncology Models Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Preclinical Oncology Models Market Restraints

Table 3. Preclinical Oncology Models Market Trends

Table 4. Preclinical Oncology Models Industry Policy

Table 5. Global Preclinical Oncology Models Revenue by Company (2019-2023) & (US$ million)

Table 6. Global Preclinical Oncology Models Revenue Market Share by Company (2019-2023)

Table 7. Global Preclinical Oncology Models Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Preclinical Oncology Models Mergers & Acquisitions, Expansion Plans

Table 9. Global Preclinical Oncology Models Manufacturers Product Type

Table 10. China Preclinical Oncology Models Revenue by Company (2019-2023) & (US$ million)

Table 11. China Preclinical Oncology Models Revenue Market Share by Company (2019-2023)

Table 12. Global Key Players of Preclinical Oncology Models Upstream (Raw Materials)

Table 13. Global Preclinical Oncology Models Typical Customers

Table 14. Preclinical Oncology Models Typical Distributors

Table 15. By Type, Global Preclinical Oncology Models Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 16. By Application, Global Preclinical Oncology Models Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 17. By Region, Global Preclinical Oncology Models Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 18. By Region, Global Preclinical Oncology Models Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Preclinical Oncology Models Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 20. By Country, Global Preclinical Oncology Models Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Preclinical Oncology Models Revenue Market Share, 2019-2030

Table 22. Aragen Bioscience Company Information, Head Office, Market Area and Industry Position

Table 23. Aragen Bioscience Company Profile and Main Business

Table 24. Aragen Bioscience Preclinical Oncology Models Models, Specifications and Application

Table 25. Aragen Bioscience Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 26. Aragen Bioscience Recent Developments

Table 27. Vivopharm Company Information, Head Office, Market Area and Industry Position

Table 28. Vivopharm Company Profile and Main Business

Table 29. Vivopharm Preclinical Oncology Models Models, Specifications and Application

Table 30. Vivopharm Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 31. Vivopharm Recent Developments

Table 32. Bioduro Company Information, Head Office, Market Area and Industry Position

Table 33. Bioduro Company Profile and Main Business

Table 34. Bioduro Preclinical Oncology Models Models, Specifications and Application

Table 35. Bioduro Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 36. Bioduro Recent Developments

Table 37. Crown Bioscience Company Information, Head Office, Market Area and Industry Position

Table 38. Crown Bioscience Company Profile and Main Business

Table 39. Crown Bioscience Preclinical Oncology Models Models, Specifications and Application

Table 40. Crown Bioscience Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 41. Crown Bioscience Recent Developments

Table 42. Charles River Company Information, Head Office, Market Area and Industry Position

Table 43. Charles River Company Profile and Main Business

Table 44. Charles River Preclinical Oncology Models Models, Specifications and Application

Table 45. Charles River Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 46. Charles River Recent Developments

Table 47. Champion Oncology Company Information, Head Office, Market Area and Industry Position

Table 48. Champion Oncology Company Profile and Main Business

Table 49. Champion Oncology Preclinical Oncology Models Models, Specifications and Application

Table 50. Champion Oncology Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 51. Champion Oncology Recent Developments

Table 52. Envigo Company Information, Head Office, Market Area and Industry Position

Table 53. Envigo Company Profile and Main Business

Table 54. Envigo Preclinical Oncology Models Models, Specifications and Application

Table 55. Envigo Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 56. Envigo Recent Developments

Table 57. Genoway Sa Company Information, Head Office, Market Area and Industry Position

Table 58. Genoway Sa Company Profile and Main Business

Table 59. Genoway Sa Preclinical Oncology Models Models, Specifications and Application

Table 60. Genoway Sa Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 61. Genoway Sa Recent Developments

Table 62. Hera Biolabs Company Information, Head Office, Market Area and Industry Position

Table 63. Hera Biolabs Company Profile and Main Business

Table 64. Hera Biolabs Preclinical Oncology Models Models, Specifications and Application

Table 65. Hera Biolabs Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 66. Hera Biolabs Recent Developments

Table 67. Mi Bioresearch Company Information, Head Office, Market Area and Industry Position

Table 68. Mi Bioresearch Company Profile and Main Business

Table 69. Mi Bioresearch Preclinical Oncology Models Models, Specifications and Application

Table 70. Mi Bioresearch Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 71. Mi Bioresearch Recent Developments

Table 72. Pharmatest Services Company Information, Head Office, Market Area and Industry Position

Table 73. Pharmatest Services Company Profile and Main Business

Table 74. Pharmatest Services Preclinical Oncology Models Models, Specifications and Application

Table 75. Pharmatest Services Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 76. Pharmatest Services Recent Developments

Table 77. Taconic Biosciences Company Information, Head Office, Market Area and Industry Position

Table 78. Taconic Biosciences Company Profile and Main Business

Table 79. Taconic Biosciences Preclinical Oncology Models Models, Specifications and Application

Table 80. Taconic Biosciences Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 81. Taconic Biosciences Recent Developments

Table 82. The Jackson Laboratory Company Information, Head Office, Market Area and Industry Position

Table 83. The Jackson Laboratory Company Profile and Main Business

Table 84. The Jackson Laboratory Preclinical Oncology Models Models, Specifications and Application

Table 85. The Jackson Laboratory Preclinical Oncology Models Revenue and Gross Margin, 2019-2023

Table 86. The Jackson Laboratory Recent Developments

List of Figure

Figure 1. Preclinical Oncology Models Picture

Figure 2. Global Preclinical Oncology Models Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Preclinical Oncology Models Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Preclinical Oncology Models Market Share of Global

Figure 5. Global Preclinical Oncology Models Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 6. Global Preclinical Oncology Models Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2023

Figure 7. China Preclinical Oncology Models Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 8. China Preclinical Oncology Models Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 9. Preclinical Oncology Models Industry Chain

Figure 10. Genetically Engineered Mouse Models (GEMMs)

Figure 11. Cell Line-derived Xenografts (CDX)

Figure 12. Patient-derived Xenografts (PDX)

Figure 13. Others

Figure 14. By Type, Global Preclinical Oncology Models Revenue, 2019-2030, US$ Million

Figure 15. By Type, Global Preclinical Oncology Models Revenue Market Share, 2019-2030

Figure 16. Pharmaceutical

Figure 17. Biological Experiments

Figure 18. Others

Figure 19. By Application, Global Preclinical Oncology Models Revenue, 2019-2030, US$ Million

Figure 20. By Application, Global Preclinical Oncology Models Revenue Market Share, 2019-2030

Figure 21. By Region, Global Preclinical Oncology Models Revenue Market Share, 2019-2030

Figure 22. North America Preclinical Oncology Models Revenue & Forecasts, 2019-2030, US$ Million

Figure 23. By Country, North America Preclinical Oncology Models Revenue Market Share, 2019-2023

Figure 24. Europe Preclinical Oncology Models Revenue & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, Europe Preclinical Oncology Models Revenue Market Share, 2019-2023

Figure 26. Asia Pacific Preclinical Oncology Models Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country/Region, Asia Pacific Preclinical Oncology Models Revenue Market Share, 2019-2023

Figure 28. South America Preclinical Oncology Models Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country, South America Preclinical Oncology Models Revenue Market Share, 2019-2023

Figure 30. Middle East & Africa Preclinical Oncology Models Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. U.S. Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 32. By Company, U.S. Preclinical Oncology Models Market Share, 2019-2023

Figure 33. By Type, U.S. Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 34. By Application, U.S. Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 35. Europe Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 36. By Company, Europe Preclinical Oncology Models Market Share, 2019-2023

Figure 37. By Type, Europe Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 38. By Application, Europe Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 39. China Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 40. By Company, China Preclinical Oncology Models Market Share, 2019-2023

Figure 41. By Type, China Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 42. By Application, China Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 43. Japan Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 44. By Company, Japan Preclinical Oncology Models Market Share, 2019-2023

Figure 45. By Type, Japan Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 46. By Application, Japan Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 47. South Korea Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 48. By Company, South Korea Preclinical Oncology Models Market Share, 2019-2023

Figure 49. By Type, South Korea Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 50. By Application, South Korea Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 51. Southeast Asia Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 52. By Company, Southeast Asia Preclinical Oncology Models Market Share, 2019-2023

Figure 53. By Type, Southeast Asia Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 54. By Application, Southeast Asia Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 55. India Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 56. By Company, India Preclinical Oncology Models Market Share, 2019-2023

Figure 57. By Type, India Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 58. By Application, India Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 59. Middle East & Asia Preclinical Oncology Models Revenue, 2019-2030, (US$ Million)

Figure 60. By Company, Middle East & Asia Preclinical Oncology Models Market Share, 2019-2023

Figure 61. By Type, Middle East & Asia Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 62. By Application, Middle East & Asia Preclinical Oncology Models Revenue Market Share, 2023 VS 2030

Figure 63. Research Methodology

Figure 64. Breakdown of Primary Interviews

Figure 65. Bottom-up Approaches

Figure 66. Top-down Approaches